ROIV

#569
Roivant Sciences Ltd. - Common Shares
30.2 7 USD
+1.31%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
30.13
30.28
Rango anual
0.29
32.79
Cambio diario
+1.31%
Variación mensual
+8.53%
Variación en los últimos 6 meses
+47.80%
Cambio anual
+65.32%
Cierres anteriores
29.8 8
Open
30.1 7
Mínimo
30.1 3
High
30.2 8
Volumen
1 090
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 21.77 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-51.3
Relación precio/flujo de caja
2 326.88

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Noticias